NCT06323408View on ClinicalTrials.gov

Integrated Analysis of Therapy Response and Resistence in Embryonal Tumors and Gliomas

Not yet recruitingOBSERVATIONAL
Enrollment

72

Participants

Timeline

Start Date

May 31, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

March 31, 2026

Conditions
Glioma, MalignantEmbryonal TumorMedulloblastomaEpendymoma
Interventions
DIAGNOSTIC_TEST

Tissue, blood, cerebrospinal-spinal fluid

Processing, analysis

All Listed Sponsors
lead

University Hospital Regensburg

OTHER

NCT06323408 - Integrated Analysis of Therapy Response and Resistence in Embryonal Tumors and Gliomas | Biotech Hunter | Biotech Hunter